Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

G-Money
12 hours ago
Most of you don't seem to understand that the continued use of the name zyesami undermines our company in the eyes of the world. And also with our court case. That name points back to nrxp and gives the impression that it's their drug. It's not. There is nothing verifying that zyesami is a new formulation of Aviptadil or a more stable version. Nothing.

If you plan to share videos and news reports etc... they need to point back to Relief Therapeutics and RLF-100. We own the formulation. If we don't educate the world on RLF -100 they will falsely believe nrxp is responsible for Aviptadil.

They are facing class action lawsuits, criminal lawsuits, SEC investigation, Dept. Of Justice investigations, and possibly FBI investigation. We don't want to be associated with nrxp.
Less

ReplyReplies (9)205
Sign in to post a reply.
Michael
Michael8 hours ago
@DD to win your understanding of how things work is way off. Gotta block you simpleton.


GeraldS
8 hours ago
Gee. With all due respect are you a lowly share holder (how many million shares at what prices) an insider on the board of directors or a lawyer suing NRXP? 1. The companies have already declared their preference for an amicable settlement so IMHO whatever we call this peptide on a public anonymous discussion board doesn't mean a hill of beans. How about "Soylent Green"?
Less

WONG
8 hours ago
@DD to win Wow, so sensitive. You act as though JJ created Zyesami himself with his at home Mr. Wizard chemistry set. Nephron reformulated the existing formulation. Not JJ. It wasn't even JJ's idea to use aviptadil to treat Covid. Give it up already. How do we even know there is a new formulation?
Bullish

DD to win
9 hours ago
@WONG ZyeSami is the current IV Aviptadil treatment under trials and continues to be the only therapeutic for critical covid patient patients.

Perhaps RLFTF should formulate an adequate IV treatment on their own. That will take over a year or more.

These two companies need to resolve their issues and split the proceeds according to their new CA they are working on.
Less

WONG
9 hours ago
Zyesami is the commercial name for RLF-100 (Aviptadil) in the states if NRXP is still bringing it to market here. We will know when the mediation is over.
Bullish


DD to win
10hours ago
You need to read more and post less misinformation. The CA spells everything out you're missing.

HOID.
11 hours ago
@HOID. I’ve been using all three for the time being. Zyesami RLF-100 Aviptadil.

HOID.
11 hours ago
I have been conflicted on this in my messaging. More so now than ever since the Senators letter mentions Zyesami. That’s the wave I will have to ride for the time being.

James
11 hours ago
You didn’t think about this too hard before posting.

~ posted at Y@h00 RLFTF finance conversations

THE UNTOLD TRUTH….